Sponsor WEB
Chapter Events
Why Join WEB?

What Is Happening at Your WEB Chapter

At the national level, WEB sponsors webinars and offers publications and other resources to its members.

Chapters offer networking events for opportunities to meet face-to-face with other benefits professionals and educational events for opportunities to learn more about employee benefit trends, design, compliance and services.

View Our Chapters
WEB Job Bank
Start a WEB Chapter
See the Members of WEB
Global Benefits Guides published by Thomson Reuters

Featured Benefits News

The latest updates in trends, best practices and compliance

  • Highlights of 2023 PBGC Meeting With ABA’s Joint Committee on Employee Benefits

    On September 11, 2023, the American Bar Association (“ABA”) posted a summary of the May 3, 2023, meeting between representatives of the Pension Benefit Guaranty Corporation (“PBGC”) and representatives of the ABA’s Joint Committee on Employee Benefits (“JCEB”). Two Wagner Law Group attorneys — Israel Goldowitz (former PBGC Chief Counsel) and Harold Ashner (former PBGC Assistant General Counsel for Legislation and Regulations) – coordinated the meeting for the JCEB representatives.

  • District Court Dismisses Employees' COBRA Election Notice Claims, Save One

    In litigation involving an employer's alleged notice violations under the Consolidated Omnibus Budget Reconciliation Act of 1985 (COBRA), a district court rejected almost all of the employees' claims for why the notices were deficient. In the one claim that survived dismissal, an employee who was terminated in June 2020 alleged that the employer's COBRA election notice failed to state an enrollment deadline that accurately reflected COVID-19-related time extensions.

  • Fifth Circuit Partially Upholds Stay Order in Medication Abortion Litigation

    In litigation involving the Food and Drug Administration's (FDA's) approval process for mifepristone (a widely used medication abortion drug), the Fifth Circuit vacated a portion of a lower court order staying the FDA's initial approval of mifepristone. However, the Fifth Circuit affirmed the portion of the lower court's order that stayed the FDA's administrative actions from 2016 (and more recent years) that generally relaxed certain safeguards involving the use of mifepristone.